Women’s Health
-
Evvy Secures $14M for Vaginal Healthcare Platform
Evvy’s $14 million funding round was led by Left Lane Capital and included participation from General Catalyst, LabCorp Venture Fund, RH Capital, Ingeborg Investments, G9 Ventures, Virtue and Amboy Street Ventures. In total, Evvy has raised $19 million.
-
Introducing MedCity FemFwd, a New Podcast on Women’s Health
MedCity News is launching a new podcast called MedCity FemFwd, which will discuss the breakthroughs and challenges in the women’s health space. In the inaugural episode, Michelle Long of KFF examines whether Opill — the first daily oral contraceptive approved for nonprescription use in the U.S. — will be covered by insurance.
-
Payer’s Place: Dawn Maroney
Dawn Maroney, President, Markets of Alignment Health and CEO of Alignment Health Plan, to discuss how they are using technology to provide better service and care to consumers.
-
Applying Remote Patient Monitoring to Surgery Prep and Recovery, Oncology and Women’s Health
A webinar sponsored by AVIA Health and SeamlessMD will discuss the latest trends in remote monitoring and how to extend these benefits beyond chronic conditions all while using fewer staff resources.
-
Visana Health Secures $10.1M for Virtual Women’s Health Platform
Visana Health’s seed funding was led by Flare Capital Partners and Frist Cressey Ventures and included participation from InHealth Ventures, Oxeon Partners, Pixel Perfect Ventures and Venture Investors. In total, the company has raised more than $13 million.
-
MedCity Influencers, Health Tech
4 New Femtech Innovations Demystifying and Normalizing Menstruation
FemTech is at the forefront of providing effective solutions to menstrual challenges, and the efforts to normalize and destigmatize menstruation are paving the way for the democratization of women’s healthcare.
-
Consumer / Employer, Health Tech
Progyny Dips Into Menopause Support
Traditionally offering family building support, Progyny is expanding into the menopause space. Employees of its employer customers will receive a personalized care plan that includes support for nutrition, sleep, mental health and hormonal health — all factors that affect menopause.
-
The “M” Word: Confronting the Critical Gap in Women’s Health Care
We need to create a care model that doesn’t treat menopause as some separate gray area of women’s health where doctors are unequipped and patients are left to their own devices to figure it out.
-
HerMD Snags $18M to Open More Menopause-Focused Health Centers
HerMD recently raised $18 million in a Series A-1 funding round. The company offers in-person and virtual women’s healthcare that focuses on menopause and sexual health. It is using its new capital to open more brick-and-mortar women’s health centers across the country.
-
Startup Sues Athenahealth, Alleging Trade Secret Theft & Deceptive Practices
Digital health startup Dorsata filed a lawsuit against EHR provider athenahealth and women’s health company Unified Women’s Healthcare. The startup alleged that athenahealth stole trade secrets, used deceptive business practices and breached its contract — and that Unified aided and abetted these purported practices.
-
Applying Remote Patient Monitoring to Surgery Prep and Recovery, Oncology and Women’s Health
Join us to learn about the latest trends in remote monitoring and how to extend its benefits beyond chronic conditions to more patients – all while using fewer staff resources.
-
Herself Health Secures $26M To Bring Primary Care to Women Ages 65+
Herself Health’s $26 million Series A funding round was led by Michael Cline, founding managing partner of Accretive, and included participation from Juxtapose. It comes six months after Herself Health raised $7 million in seed funding. In total, the company has raised $33 million.
-
FDA Nod Makes Perrigo’s Opill the First Oral Contraceptive to Switch to OTC Use
FDA approval of Opill makes it the first oral contraceptive that may be used without a prescription. Clinicians say over-the-counter availability will lower barriers to access to a key component of reproductive healthcare.
-
Pharma, BioPharma, Health Tech
Women’s Health Startups Graduate from PharmStars Digital Health Accelerator
A new cohort of startups has graduated from PharmStars, a digital health accelerator. This latest group focused on women’s health and health equity.
-
How Data for ImmunoGen Drug Could Change the Way Doctors Treat Ovarian Cancer
In a confirmatory Phase 3 test of ImmunoGen’s Elahere, the ovarian cancer drug handily beat chemotherapy with results that clinicians say could make the treatment the new standard of care for certain patients. The data were presented during the annual meeting of the American Society of Clinical Oncology.
-
FDA Approves First-Of-Its Kind Drug to Ease Menopause Symptoms
Astellas Pharma won FDA approval for Veozah, a new menopause drug. The once-daily pill offers a new non-hormonal treatment option for addressing menopausal symptoms.
-
Intrinsic Secures $15M for Women’s Health-focused Consumer Goods
Intrinsic acquires and sells brands that fill unmet women’s health needs. Its $15 million funding round brings the company’s total funding to $128 million, with investors including FCA Venture Partners, MAP Investco, Define Ventures, Link Ventures and Redesign Health.
Promoted
Payer’s Place: Dr. Anil Singh
Dr. Anil Singh shares his insights into the strategies employed by the organization to identify the most effective digital solutions for their members.
Promoted
Discover the Next-Gen Platform for Integrated Collaborative Care
Beyond EHRs and digital front doors, reducing the gaps in patient care journeys.
